Session 897: Precursor lesions

Date: 2 February 2004, Time: 14:00 - 16:00
Location: Room 3

Oral Presentations

Time	Number	Title / Authors / Affiliations
14:00	269	Cyclin D1 polymorphism (G870A) and susceptibility to gastroesophageal reflux disease, Barrett's esophagus and esophageal adenocarcinoma: a case-control study AG Casson FRCSC^a,b, Z Zheng MD^b, SC Evans BSc^b, PJ Veugelers PhD^c, GA Porter MD^a, DL Guernsey PhD^a,b ^aDepartment of Surgery, ^bPathology, ^cCommunity Health and Epidemiology; Dalhousie University, Halifax, Nova Scotia, Canada
14:20	270	Clinicopathologic analysis in 13823 cancers of esophagus and cardia as well as a comparative analysis of c-fos and Egr-1 expression on 47 esophageal carcinoma cases in Chaoshan littoral region of China M Su MD^a, YM Wu MD^a, XY Li MD^a, DP Tian MD PhD^a, SM Lu MD^c, HX Yang MD^a, H Zhao PhD^a, DR Li MD^b, ZC Zheng MD^d, XH Xiu PhD^a (a)Dept.of Pathology, Shantou University Medical College, China. (b)The tumor Hospital of Shantou University Medical College. (c)The first affiliated hospital of Shantou University Medical College. (d)The second affiliated hospital of Shantou University Medical College.
14:35	271	Analysis of the gastric mutations induced by chronic Helicobacter pylori infections in a mouse model and influence of high-salt diet. E Touati PhD^a,b, T Michel^a,b,a,b, P Avé, M Huerre MD, A Labigne PhD^a,b ^aUnité de Pathogénie Bactérienne des Muqueuses, ^bUnité de Recherche et d’Expertise en Histotechnologie et Pathologie; Institut Pasteur, Paris cedex 15, France
14:50	272	Cyclin D1, TP53 and nitrotyrosine expression in gastroesophageal reflux-induced esophagitis, Barrett's esophagus and esophageal adenocarcinoma L Geldenhuys MD^a, Z Zheng MD^a, KA Gallant BSc^a, NM Vaninetti BSc^a, SC Evans BSc^a, PJ Veugelers PhD^b, DL Guernsey PhD^a, AG Casson FRCSC^c ^aDepartment of Pathology, ^bCommunity Health and Epidemiology, ^cSurgery; Dalhousie University, Halifax, Nova Scotia, Canada
15:05	273	Chronic Helicobacter pylori infection may result in gastric cancer in hypergastrinemic mice but not in gastrin-deficient mice C-M Zhao PhD^a,d, X Wang MD PhD^b, L Friis-Hansen MD PhD^c, HL Waldum MD PhD^d, J Halgunset MD^d, T Wadström MD PhD^b, D Chen MD PhD^a,d ^aCancer Research Unit, Cancer Clinic, St. Olavs Hospital, Trondheim, Norway, ^bDepartment of Immunology, University of Lund, Lund, Sweden, ^cDepartment of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark, ^dDepartment of Cancer Research and Molecular Medicine and Laboratory Medicine, Norwegian University of Science and Technology, Trondheim, Norway
15:20	274	Premalignant lesions in breast, ovary and Fallopian tube in prophylactically removed tissue from women at hereditary high risk for breast and ovarian cancer B Hermsen MD^a, S von Mensdorff-Pouilly MD PhD^a, P van Diest MD PhD^b, F Menko MD PhD^c, J Piek MD^a, H Fabry MD^d, P Kenemans MD PhD^a, RHM Verheijen MD PhD^a ^aDepartment of Obstetrics and Gynaecology, ^bDepartment of Pathology, ^cDepartment of Clinical and Human Genetics, ^dDepartment of Surgery; VU University Medical Centre, Amsterdam, Netherlands

Poster Presentations

Number	Title / Authors / Affiliations
275	Infection with HPV 16 or HPV 18 variants and risk of low-grade squamous intraepithelial lesions in young women H Richardson PhD^a,b, F Coutlée MD^e, M Abrahamowicz PhD^b, P Tellier MD^c, G Kelsall MA^a,c, H Voyer BSc^e, A Ferenczy MD^a,d, EL Franco PhD^a,b ^aDepartment of Oncology, ^bEpidemiology & Biostatistics, ^cFamily Medicine, ^dPathology; McGill University, Montreal, Canada, ^eLaboratoire de Virologie Moleculaire, Centre de Recherche et Departement de Microbiologie et Infectiologie, Hôpital Notre-Dame du Centre Hospitalier de l’Université de Montréal, Montreal, Canada
276	Immunohistochemical detection of acetylation and phosphorylation of histone H3 in cervical smears M Anton MD, M Horký, Š Helánová, P Češková Department of Experimental Oncology, Masaryk Cancer Institute, Žlutý kopec 7, 656 53 Brno, Czech Republic
277	Screening of primary sclerosing cholangitis patients by quantitative DNA analysis of bile duct specimens in order to schedule patients at high risk for liver transplantation H Al-Abadi MD^a, R Hintze^b, H Abou-Rebyeh MD^b, S Jonas MD^a, CTIAC Rotter^a, P Neuhaus MD^a (a) Dept. General-, Visceral- and Transplantation Surgery, Laboratory of Clinical Cytology and DNA-cytometry, (b) Dept. Hepatology and Gastroenterology; Charité, Humboldt University, Berlin, Germany.
278	Glutathione S-transferse-pi expression in matched human normal, reflux, esophagitis, Barrett's esophagus and esohagus cancer mucosa Y Rasmi^a, AA Allameh PhD^a, N Moghaddam MD^b, SM Tavangar MD^b, M Sadreddini MD^b ^aDepartment of Clinical Biochemistry, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran, ^bDigestive Disease Research Center, Shariati Hospital, Tehran, Iran
279	Variable cyclooxygenase (COX)-2 expression in Barrett’s associated adenocarcinoma: relationship to tumor differentiation S Abdalla^a,b, IR Sanderson^b, MR Novelli^c, LB Lovat^c, RC Fitzgerald^a (a) Cancer Cell Unit, MRC/Hutchison Building, Cambridge, UK (b) The Adult and Paediatric Gastroenterology Department, Barts and The London School of Medicine and Dentistry, London, UK (c) University College, London
280	Gastrin induces cyclooxygenase (COX)-2 expression in Barrett’s esophagus S Abdalla^a,b, PS Sirieix^a, IR Sanderson^b, RC Fitzgerald^a ^aCancer Cell Unit, MRC/Hutchison Building, Cambridge, United Kingdom, ^bThe Adult and Paediatric Gastroenterology Department, Barts and The London School of Medicine and Dentistry, London, United Kingdom